A Comprehensive Review of Capsaicin and Its Role in Cancer Prevention and Treatment

Abstract

This study examines the fundamental chemical mechanisms responsible for capsaicin's advantageous impact on cancer, specifically investigating its influence on several biological processes such as inflammation in cancer metastasis, apoptosis, angiogenesis, and cellular proliferation. This entity's connections with other signaling pathways, including PI3K/AKT, NF-B, and TRPV channels, which have been linked to tumor growth, are thoroughly examined in this work. This study presents a thorough analysis of preclinical studies and clinical trials investigating the efficacy of capsaicin in treating many forms of cancer, such as breast, prostate, colorectal, pancreatic, and others. Through tests conducted in both live organisms and laboratory settings, it has been determined that capsaicin has the ability to inhibit tumor growth and induce apoptosis in cancer cells. (in vitro and in vivo). Researchers have also looked at the results of combining capsaicin with chemotherapy medications in traditional treatment. The efficacy and bioavailability of capsaicin as a viable medicinal drug are being studied, along with ways to improve its clinical value. The present investigation carefully assesses the challenges and potential options for maximizing the therapeutic benefits of capsaicin, including customized drug delivery and personalized therapeutic strategies. In finalization, this comprehensive investigation brings together the evidence currently obtainable on the anticancer properties of capsaicin, underscoring its potential as an autonomous treatment option in the struggle against cancer. Capsaicin is a compound of significant relevance for continuing research and clinical exploration in the field of cancer treatment due to its diverse mechanisms of action and ability for boosting prevailing therapy approaches.

Keywords

capsaicin - breast cancer - prostate cancer - colorectal cancer - pancreatic cancer - protein inhibition

Publication History

Received: 12 March 2024

Accepted: 16 April 2024

Article published online:
10 May 2024

• References

• 1 Kunjiappan S, Sankaranarayanan M, Kumar BK. et al. Capsaicin-loaded solid lipid nanoparticles: Design, biodistribution, in silico modeling and in vitro cytotoxicity evaluation. Nanotechnology 2020; 32: 095101
• 2 Clark R, Lee SH. Anticancer properties of capsaicin against human cancer. Anticancer Research 2016; 36: 837-843
• 3 Kang JH, Kim CS, Han IS. et al. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Letters 2007; 581: 4389-4396
• 4 Sánchez BG, Bort A, Mora-Rodríguez JM. et al. The Natural Chemotherapeutic Capsaicin Activates AMPK through LKB1 Kinase and TRPV1 Receptors in Prostate Cancer Cells. Pharmaceutics 2022; 14: 329
• 5 Sharma SK, Vij AS, Sharma M. Mechanisms and clinical uses of capsaicin. European Journal of Pharmacology 2013; 720: 55-62
• 6 Toh C, Lee T, Kiang A. The pharmacological actions of capsaicin and analogues. British Journal of Pharmacology and Chemotherapy 1955; 10: 175
• 7 Lang Y, Yanagawa S, Sasanuma T. et al. A gene encoding a putative acyl-transferase involved in pungency of Capsicum. Breeding Science 2006; 56: 55-62
• 8 Reilly CA, Ehlhardt WJ, Jackson DA. et al. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells. Chemical Research in Toxicology 2003; 16: 336-349
• 9 Raisinghani M, Pabbidi RM, Premkumar LS. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin. The Journal of Physiology 2005; 567: 771-786
• 10 Ziglioli F, Frattini A, Maestroni U. et al. Vanilloid-mediated apoptosis in prostate cancer cells through a TRPV-1 dependent and a TRPV-1-independent mechanism. Acta bio-medica: Atenei Parmensis 2009; 80: 13-20
• 11 Zhang JH, Lai FJ, Chen H. et al. Involvement of the phosphoinositide 3‑kinase/Akt pathway in apoptosis induced by capsaicin in the human pancreatic cancer cell line PANC-1. Oncology Letters 2013; 5: 43-48
• 12 Pramanik KC, Boreddy SR, Srivastava SK. Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. PloS one 2011; 6: e20151
• 13 Mori A, Lehmann SR, O'Kelly J. et al. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Research 2006; 66: 3222-3229
• 14 Moon DO, Kang CH, Kang SH. et al. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: Involvement of Ca2+ influx. Toxicology and Applied Pharmacology 2012; 259: 87-95
• 15 Chang H, Chen S, Chien S. et al. Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Human & Experimental Toxicology 2011; 30: 1657-1665
• 16 de-Sá-Júnior PL, Pasqualoto KFM, Ferreira AK. et al. RPF101, a new capsaicin-like analogue, disrupts the microtubule network accompanied by arrest in the G2/M phase, inducing apoptosis and mitotic catastrophe in the MCF-7 breast cancer cells. Toxicology and Applied Pharmacology 2013; 266: 385-398
• 17 Lu HF, Chen YL, Yang JS. et al. Antitumor activity of capsaicin on human colon cancer cells in vitro and colo 205 tumor xenografts in vivo. Journal of Agricultural and Food Chemistry 2010; 58: 12999-13005
• 18 Wang HM, Chuang SM, Su YC. et al. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth. Cell Biochemistry and Biophysics 2011; 61: 355-366
• 19 Tsou MF, Lu H-F, Chen SC. et al. Involvement of Bax, Bcl-2, Ca2+ and caspase-3 in capsaicin-induced apoptosis of human leukemia HL-60 cells. Anticancer Research 2006; 26: 1965-1971
• 20 Dimmeler S, Fleming I, Fisslthaler B. et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605
• 21 Morbidelli L, Chang C-H, Douglas JG. et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. American Journal of Physiology-Heart and Circulatory Physiology 1996; 270: H411-H415
• 22 Papapetropoulos A, García-Cardeña G, Madri JA. et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. The Journal of Clinical Investigation 1997; 100: 3131-3139
• 23 Min JK, Han KY, Kim EC. et al. Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Research 2004; 64: 644-651
• 24 Baselga J. The EGF receptor family as targets for breast cancer therapy. Breast Cancer Research 2000; 2 S. 13
• 25 Krueger JS, Keshamouni VG, Atanaskova N. et al. Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene 2001; 20: 4209-4218
• 26 Thoennissen N, O'kelly J, Lu D. et al. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and-negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene 2010; 29: 285-296
• 27 Yoon JH, Ahn SG, Lee BH. et al. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA–PKcs and PARP-1. Biochemical Pharmacology 2012; 83: 747-757
• 28 Gobeil S, Boucher C, Nadeau D. et al. Characterization of the necrotic cleavage of poly (ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death & Differentiation 2001; 8: 588-594
• 29 Virag L, Szabó C. The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacological Reviews 2002; 54: 375-429
• 30 Di Giovanni S, Mirabella M, Papacci M. et al. Apoptosis and ROS detoxification enzymes correlate with cytochrome c oxidase deficiency in mitochondrial encephalomyopathies. Molecular and Cellular Neuroscience 2001; 17: 696-705
• 31 Lee MG, Lee KT, Chi SG. et al. Constunolide induces apoptosis by ROS-mediated mitochondrial permeability transition and cytochrome c release. Biological and Pharmaceutical Bulletin 2001; 24: 303-306
• 32 Semenza GL. Targeting HIF-1 for cancer therapy. Nature Reviews Cancer 2003; 3: 721-732
• 33 Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell 2012; 148: 399-408
• 34 Han TH, Park MK, Nakamura H. et al. Capsaicin inhibits HIF-1α accumulation through suppression of mitochondrial respiration in lung cancer cells. Biomedicine & Pharmacotherapy 2022; 146: 112500
• 35 Wang HP, Pu XY, Wang XH. Distribution profiles of transient receptor potential melastatin-related and vanilloid-related channels in prostatic tissue in rat. Asian Journal of Andrology 2007; 9: 634-640
• 36 Xu S, Cheng X, Wu J. et al. Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH-TSHR pathway in anaplastic thyroid carcinoma cells. Journal of Molecular Cell Biology 2021; 13: 791-807